Stable oral liquid fenofibrate formulations that include a fenofibrate component and a pharmaceutically acceptable liquid carrier that is present in an amount sufficient to solubilize the fenofibrate and that includes a lipophilic component, a surfactant component, at least one monohydric alcohol, and optionally in some embodiments an aqueous component, wherein the formulation is substantially free of an oily phase. Also included are stable liquid fenofibrate formulations including a prophylactically or therapeutically effective amount of fenofibrate and a liquid carrier present in less than 5 ml that is sufficient to maintain dissolution of the fenofibrate under ambient temperature. Methods of preparing and administering such liquid formulations are also included.
申请公布号
WO2008144355(A2)
申请公布日期
2008.11.27
申请号
WO2008US63638
申请日期
2008.05.15
申请人
MORTON GROVE PHARMACEUTICALS, INC.;NARANG, AJIT, S.;REBBAPRAGADA, LAKSHMI;DELMARRE, DAVID;MOHAMMED, MOHSIN;GAO, DANCHEN